Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts

Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts

The creation of small-diameter tissue-engineered vascular grafts using biodegradable materials has the potential to change the quality of cardiovascular surgery in the future. The implantation of these tissue-engineered arterial grafts has yet to reach clinical application. One of the reasons for th...

Full description

Bibliographic Details
Main Authors:	Yuichi Matsuzaki, Anudari Ulziibayar, Toshihiro Shoji, Toshiharu Shinoka
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Applied Sciences
Subjects:	tissue-engineered vascular grafts biodegradable material anticoagulation medication heparin large-animal study
Online Access:	https://www.mdpi.com/2076-3417/11/10/4563

Similar Items

Clinical Application for Tissue Engineering Focused on Materials
by: Takahiro Kitsuka, et al.
Published: (2022-06-01)

Construction of tissue-engineered vascular grafts with enhanced patency by integrating heparin, cell-adhesive peptide, and carbon monoxide nanogenerators into acellular blood vessels
by: Yonghong Fan, et al.
Published: (2024-04-01)

The Application of Porous Scaffolds for Cardiovascular Tissues
by: Tatsuya Watanabe, et al.
Published: (2023-02-01)

A Brief Report on an Implantation of Small-Caliber Biodegradable Vascular Grafts in a Carotid Artery of the Sheep
by: Larisa V. Antonova, et al.
Published: (2020-05-01)

Nanofibers with homogeneous heparin distribution and protracted release profile for vascular tissue engineering
by: Hongmei Zhang, et al.
Published: (2023-06-01)

Pharmacological properties of hirudin and its derivatives : potential clinical advantages over heparin /
by: 422288 Monreal, Manuel, et al.

Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model /
by: Walenga, J. M.

Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-relared inhibitors /
by: Brankamp, R. G.

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

Advances in Cardiac Tissue Engineering
by: Takahiro Kitsuka, et al.
Published: (2022-11-01)

Comparing the Effects of Three Heparinization Methods of Hemodialysis Set on the Amount of Clot Formation during Hemodialysis
by: M Kazemi, et al.
Published: (2005-07-01)

Heparin in sepsis: current clinical findings and possible mechanisms
by: Sihan Yu, et al.
Published: (2024-12-01)

Results of preclinical trials in a sheep model of biodegradable small-diameter vascular grafts
by: L. V. Antonova, et al.
Published: (2022-09-01)

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin : comparison with heparin and recombinant hirudin /
by: Berry, Christopher N.

Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
by: Niranjan Koirala, et al.
Published: (2025-02-01)

Recent Developments in Biopolymer-Based Hydrogels for Tissue Engineering Applications
by: Rikako Hama, et al.
Published: (2023-02-01)

Effects of Protamine Reversal on Coagulation Parameters After High-Dose Heparin Administration in Percutaneous Hepatic Chemosaturation Intervention
by: Michael Metze, et al.
Published: (2025-02-01)

Biological Materials for Tissue-Engineered Vascular Grafts: Overview of Recent Advancements
by: Dalila Di Francesco, et al.
Published: (2023-09-01)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01)

Potential targets of heparin during progression and metastasis of malignant neoplasms
by: V. V. Malashchenko, et al.
Published: (2024-01-01)

Preparation, Anticoagulant and Antioxidant Properties of Glucosamine-Heparin Salt
by: Qin Miao, et al.
Published: (2022-10-01)

Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
by: Lorenzo A. Alberio, et al.
Published: (2020-04-01)

HEPARIN-INDUCED THROMBOCYTOPENIA (REVIEW)
by: S. A. Vasiliev, et al.
Published: (2019-06-01)

Comparative Evaluation on Impacts of Fibronectin, Heparin–Chitosan, and Albumin Coating of Bacterial Nanocellulose Small-Diameter Vascular Grafts on Endothelialization In Vitro
by: Max Wacker, et al.
Published: (2021-07-01)

Heparin induced thrombocytopenia in pregnancy: A therapeutic challenge case report and literature review
by: Seyyed Mojtaba Nekooghadam, et al.
Published: (2023-08-01)

Current Status of Bioprinting Using Polymer Hydrogels for the Production of Vascular Grafts
by: Jana Matějková, et al.
Published: (2024-12-01)

Heparin-resistance in AL amyloidosis: a case report
by: Elisabeth S. van Ede, et al.
Published: (2023-06-01)

Dehydration improves biomechanical strength of bioartificial vascular graft material and allows its long-term storage
by: Aper Thomas, et al.
Published: (2018-07-01)

Improved porosity promotes reendothelialization and smooth muscle remodeling in decellularized tissue-engineered vascular grafts
by: Tun Wang, et al.
Published: (2025-02-01)

Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study
by: Danielle Green, et al.
Published: (2024-12-01)

Heparin-Induced Thrombocytopenia under Mechanical Circulatory Support by Large Impella for Acute Cardiogenic Shock
by: Yukiharu Sugimura, et al.
Published: (2021-11-01)

Construction of vascular grafts based on tissue-engineered scaffolds
by: Zhongliang Lang, et al.
Published: (2024-12-01)

The Effect of Polybrene on an aPTT-based Lupus Anticoagulant Test in the Plasma of Patients Receiving Unfractionated Heparin
by: Chulalak Kongkan, et al.
Published: (2023-01-01)

Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis
by: Michelle Sholzberg, et al.
Published: (2021-12-01)

Vascularized Palmaris Longus Tendon Graft in Delayed Tendon Injuries of Hand
by: Yog Raj Handoo

ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19
by: Claire Coutureau, et al.
Published: (2022-04-01)

Approaches to Assure Similarity between Pharmaceutical Heparins from Two Different Manufacturers
by: Francisco Felipe Bezerra, et al.
Published: (2023-03-01)

Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy
by: Razia Sultana, et al.
Published: (2024-10-01)

Quercetin-Loaded Nanoparticle-Modified Decellularized Tissue-Engineered Vascular Graft Regulates Macrophage Polarization and Promotes In Vivo Graft Remodeling
by: Wang T, et al.
Published: (2025-03-01)

International normalized ratio measurement during perioperative anticoagulation bridging with low-molecular-weight heparin in patients undergoing heart valve replacement surgery
by: Liza Rijvers, et al.
Published: (2024-11-01)